Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High-flow Nasal Oxygen Therapy to Prevent Extubation Failure in Adult Trauma Intensive Care Patients

NCT06110390 is registered in ClinicalTrials.gov with Hamad Medical Corporation as lead sponsor.

NCT NCT06110390
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06110390 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High-flow Nasal Oxygen Therapy to Prevent Extubation Failure in Adult Trauma Intensive Care Patients
Lead sponsor
Hamad Medical Corporation
Phase
Not applicable
Overall status
Unknown status
Start date
October 17, 2020
Completion date
February 29, 2024
Enrollment
450 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

airway extubation, critical care, intensive care, oxygen therapy